relationship
infect
vascul
complex
take
consider
exampl
histor
diseas
tubercul
syphilit
aortiti
infect
long
suspect
trigger
factor
mani
type
vascul
howev
causal
relationship
firmli
establish
instanc
use
epidemiolog
approach
eg
pan
hbv
cryoglobulinaemia
hcv
case
howev
link
remain
hypothet
without
formal
evid
physiopatholog
interrelationship
remain
poorli
understood
immun
autoimmun
mechan
respons
vascul
recent
antibodi
anca
andor
key
compon
apoptosi
found
involv
pathogenesi
variou
type
vascul
anim
model
import
contribut
field
use
mous
model
ancaassoci
vascul
huugen
et
al
use
model
passiv
transfer
antimpo
antibodi
prepar
mpo
knockout
mice
transfer
antimpo
igg
mice
control
mice
receiv
antibsa
antibodi
one
hour
administr
antimpo
bacteri
lipopolysaccharid
lp
also
inject
intraperiton
mice
clinic
manifest
haematuria
leucocyturia
patholog
find
necrot
crescent
glomerulonephr
sever
mice
receiv
lp
suggest
lp
aggrav
factor
antimpo
vascul
author
recent
report
sever
lung
granulomat
vascul
intraven
inject
fa
ligand
murin
anim
model
also
experiment
anim
model
vascul
suggest
infect
could
trigger
vascul
andor
interfer
differ
immun
mechan
includ
parvoviru
infect
aleutian
mink
lead
vascul
similar
human
pan
epidem
equin
coronaviru
infect
follow
endotheli
infect
local
inflamm
fibrinoid
necrosi
furthermor
streptococc
toxin
inject
ear
arteri
rabbit
vasculit
syndrom
induc
chlamydia
pneumonia
shown
induc
aortic
vascul
rabbit
rna
viru
andor
herp
viru
produc
aortiti
andor
diseas
inbr
mous
strain
vascul
great
vessel
describ
mice
lack
respons
immunohistochem
studi
show
viru
infect
mice
follow
sever
panarter
howev
although
viru
high
tropism
media
elast
arteri
site
seem
allow
persist
pathogen
vascul
limit
recent
paessler
et
al
describ
anim
model
eastern
equin
enceph
infect
golden
hamster
eastern
equin
enceph
viru
respons
sever
human
arbovir
diseas
usa
result
histolog
find
vascul
cerebr
microhaemorrhag
similar
describ
human
sever
mechan
could
involv
primari
vascul
relat
infect
type
iii
immun
complex
reaction
antigen
infecti
agent
antigen
portion
zone
equival
reach
immun
complex
precipit
becom
trap
within
vessel
wall
stimul
immun
respons
lead
vascular
injuri
candida
polysaccharid
fragment
gramposit
gramneg
organ
activ
altern
pathway
also
lead
inflammatori
reaction
characterist
vascul
vascul
result
deposit
circul
immun
complex
repres
pan
associ
hbv
infect
cryoglobulinaemia
associ
system
vasculitid
mainli
consequ
hcv
infect
hsp
result
deposit
mesangium
vessel
iga
form
complex
histolog
reveal
mainli
deposit
immun
complex
form
viral
antigen
antibodi
respons
activ
classic
complement
pathway
recruit
neutrophil
ie
pan
associ
hbv
infect
cryoglobulinaemia
report
patient
consid
associ
increas
death
risk
andor
neoplasia
howev
product
circul
cryoglobulin
seem
relat
hiv
infect
strongli
correl
hcv
coinfect
liver
cirrhosi
recent
featur
cryoglobulinaemia
vascul
studi
hiv
hcv
coinfect
patient
therefor
coinfect
patient
higher
liver
inflamm
higher
gammaglobulinaemia
lower
cryoglobulin
level
moreov
antihcv
therapi
benefici
popul
associ
hiv
infect
significantli
reduc
clinic
immunolog
express
cryoglobulinaemia
except
coinfect
patient
high
viral
load
virus
cryoglobulinaemia
studi
coinfect
patient
relat
cell
count
aaron
et
al
result
data
suggest
cellmedi
immun
could
contribut
product
hcvassoci
cryoglobulin
ii
cellmedi
hypersensit
antigen
exposur
may
attract
lymphocyt
liber
cytokin
caus
tissu
damag
activ
macrophag
lymphocyt
gca
gca
instanc
exposur
antigen
probabl
infecti
clear
evid
support
data
trigger
tcell
driven
process
lead
vascul
dendrit
cell
vascular
wall
potent
antigenpres
cell
therefor
abl
activ
cell
respons
macrophag
monocyt
recruit
vessel
wall
cell
releas
sever
cytokin
tissueresid
cell
releas
key
proinflammatori
cytokin
implic
pathogenesi
gca
sustain
inflamm
mediat
cell
macrophag
proinflammatori
cytokin
lead
intim
thicken
vessel
occlus
plateletderiv
growth
factor
vascular
endotheli
growth
factor
also
play
import
role
subsequ
develop
lumenocclus
arter
pan
associ
hbv
classic
exampl
primari
vascul
relat
infecti
agent
reliabl
anim
model
pan
relat
hbv
virolog
preval
studi
support
formal
causal
associ
pan
hbv
report
frequent
usual
within
first
month
hbv
infect
recent
year
import
decreas
hbvpan
primarili
due
hbv
vaccin
full
pretransfusion
blood
screen
minor
clinic
differ
notic
hbvpan
compar
noninfecti
pan
includ
dramat
onset
milder
favour
clinic
cours
seroconvers
follow
complet
heal
biolog
hbvpan
reveal
constant
viral
replic
hbsag
case
inconst
immun
complex
less
case
pan
associ
hcv
retrospect
studi
import
clinicopatholog
featur
therapeut
differ
found
hcvpan
vascul
hcvcryoglobulinaemia
infecti
agent
report
pan
without
formal
evid
data
tabl
distinct
done
pan
hbvrelat
pan
sinc
import
differ
pathogenesi
consequ
treatment
prognosi
vidarabin
use
prospect
uncontrol
studi
result
improv
surviv
seroconvers
case
furthermor
guillevin
et
al
demonstr
shortterm
corticosteroid
plasma
exchang
antivir
therapi
hbvpan
effect
safe
major
case
cryoglobulinaemia
hcv
relat
link
establish
sinc
sever
year
studi
shown
mix
cryoglobulinaemia
common
chronic
hcv
infect
predominantli
type
ii
data
serolog
virolog
investig
support
pathophysiolog
role
hcv
infect
cryoglobulinaemia
posit
antihcv
test
patient
circul
hcvrna
hcv
lesion
hcvrna
cryoprecipit
furthermor
sansonno
et
al
shown
hcvrna
level
circul
lymphocyt
patient
mix
cryoglobulinaemia
significantli
higher
compar
observ
noncryoglobulinaem
patient
recent
data
identifi
hcv
genotyp
genotyp
frequent
associ
cryoglobulinaemia
genotyp
associ
cryoglobulinaemia
coinfect
patient
symptom
cryoglobulinaemia
relat
hcv
mainli
cutan
rheumatolog
renal
howev
correl
liver
diseas
activ
score
cryoglobulinaemia
report
preval
cryoglobulin
hcv
patient
preval
symptom
associ
presenc
cryoglobulin
cryoglobulinaemia
also
secondari
hbv
infect
relationship
hbv
cryoglobulinaemia
establish
sinc
detect
hbv
type
iii
cryoglobulinaemia
levo
found
hbv
marker
hbsag
antibodi
cryoprecipit
twothird
patient
mix
cryoglobulinaemia
relat
lymphoprolif
diseas
ctd
serum
specimen
sera
posit
hbsag
antihbv
antibodi
hbv
hcv
similar
epidemiolog
characterist
case
cryoglobulinaemia
associ
hbv
infect
report
literatur
enabl
determin
precis
role
coinfect
hcv
seri
consecut
patient
preval
cryoglobulin
found
significantli
higher
p
hcv
patient
hbv
patient
cryoglobulinaemia
occasion
report
hiv
cmv
ebv
parvoviru
infect
sporad
report
formal
conclus
could
drawn
tabl
recent
studi
hivinfect
subject
howev
show
viru
play
import
role
product
cryoglobulin
misiani
et
al
report
benefit
vs
inf
prospect
random
control
trial
treat
popul
circul
hcvrna
disappear
case
sinc
success
treatment
hcvassoci
cryoglobulinaem
glomerulonephr
protocol
combin
ribavirin
could
consid
hcvcryoglobulinaemia
howev
nowaday
new
therapi
monoclon
antibodi
administr
also
discuss
treatment
patient
sever
data
suggest
autoimmun
infecti
pathogenesi
wg
diseas
character
perman
tcell
activ
flareup
initi
respiratori
tract
infect
circul
immun
complex
presenc
granuloma
nowaday
clear
evid
infecti
trigger
wg
although
sever
report
support
staphylococcu
aureu
major
role
relationship
aureu
wg
first
suggest
wegen
et
al
support
recent
data
stegeman
et
al
demonstr
strong
associ
aureu
carriag
wg
relaps
select
reactiv
tcell
clone
aureu
report
prolong
administr
cotrimoxazol
diminish
relaps
rate
effici
case
unrespons
treatment
suggest
either
immunosuppress
effect
via
folic
acid
antagon
infecti
trigger
relaps
infect
may
play
sever
role
wg
therefor
mediat
inflamm
local
releas
induc
endotheli
cell
activ
neutrophil
prime
ancamedi
pmn
activ
cellwal
compon
aureu
repres
power
mitogen
stimul
autoreact
b
cell
produc
anca
suggest
aureu
phosphatas
act
plant
antigen
initi
glomerulonephr
vascul
addit
microbi
antigen
may
act
superantigen
caus
select
expans
cell
bear
particular
tcr
chain
variabl
region
author
report
abnorm
expans
cell
use
gene
product
group
observ
increas
gene
usag
vascul
howev
recent
studi
contest
aureu
superantigen
activ
despit
product
superantigen
toxin
nasal
carriag
aureu
peripher
tlymphocyt
repertoir
bia
found
addit
aureu
sever
infecti
agent
also
report
wg
without
consist
evid
tabl
case
parvoviru
wg
main
dilemma
whether
pathogen
repres
aetiolog
agent
lead
opportunist
infect
relationship
nocardia
wg
also
unclear
one
report
case
nocardia
infect
mimick
wg
triad
also
case
nocardia
infect
appear
wg
evolut
due
immunosuppress
present
diseas
infecti
aetiolog
suspect
kawasaki
diseas
kd
base
mainli
epidemiolog
characterist
clinic
multisystem
present
therefor
kd
display
age
distribut
similar
childhood
infect
common
boy
male
femal
ratio
observ
mani
infecti
diseas
sex
differ
immun
respons
suggest
mediat
suscept
season
variat
kd
incid
observ
differ
geograph
region
furthermor
clinic
featur
diseas
also
characterist
sever
acut
childhood
infect
al
epidemiolog
data
could
suggest
infecti
aetiolog
kd
sever
pathogen
report
diseas
without
clear
evid
contribut
pathogenesi
tabl
laboratori
techniqu
microbiolog
molecular
serolog
method
far
unabl
identifi
aetiolog
agent
molecular
techniqu
fail
detect
circul
conserv
microbi
sequenc
kd
suggest
either
antigen
stimulu
may
aris
distant
site
andor
may
hostderiv
factor
involv
proinflammatori
cascad
howev
possibl
environment
factor
influenc
aetiolog
possibl
modul
infect
risk
remain
suggest
anim
model
henc
shown
microbi
compon
lactobacillu
andor
candida
inject
anim
model
induc
coronari
arter
lehman
et
al
immun
sever
mous
strain
intraperiton
inject
lactobacillu
case
cell
wall
extract
lcwe
observ
coronari
arter
day
immun
similar
manner
candida
albican
water
solubl
fraction
infus
intraperiton
sever
mous
strain
induc
coronari
vascul
associ
high
product
superantigen
mechan
suggest
may
relat
infecti
agent
sinc
kd
share
mani
clinic
featur
superantigenmedi
diseas
occasion
report
concurr
children
toxic
shock
syndrom
caus
superantigen
superantigen
bind
region
tcr
clonal
expans
cell
observ
author
kd
find
inconsist
duong
et
al
use
similar
model
lcwe
genet
modifi
mice
express
human
human
mhc
class
ii
transgen
background
lack
endogen
observ
mice
display
humanlik
respons
bacteri
antigen
vitro
studi
shown
superantigen
activ
lcwe
fraction
directli
correl
capac
lcwe
induc
coronari
lesion
furthermor
use
anim
model
huiyuen
et
al
report
tnf
blocker
etanercept
could
prevent
develop
arter
suggest
role
proinflammatori
cytokin
pathogenesi
kd
epidemiolog
laboratori
data
support
infecti
superantigen
hypothesi
lack
although
data
may
reflect
involv
yet
unidentifi
superantigen
human
furthermor
combin
antigen
superantigen
mechan
propos
nevertheless
pathogen
mechan
kd
seem
multifactori
requir
certain
immunolog
genet
factor
probabl
vector
although
aetiopathogenesi
takayasu
arter
ta
unknown
increas
number
activ
circul
cell
local
vascular
lesion
suggest
cell
implic
initi
diseas
nevertheless
put
trigger
antigen
still
unknown
long
mycobacterium
tuberculosi
thought
possibl
aetiolog
agent
ta
convinc
data
except
one
studi
although
sever
clinic
studi
unabl
find
correl
infect
vascul
data
concern
implic
infecti
agent
ta
came
anim
model
fong
et
al
laitinen
et
al
report
aortic
inflamm
c
pneumonia
infect
observ
bacteri
antigen
intim
endotheli
cell
immunohistochemistri
rna
viru
porcin
reproduct
respiratori
syndrom
viru
prrsv
herp
viru
also
found
induc
vessel
inflammatori
lesion
pig
respect
mous
model
rossow
et
al
report
multifoc
system
diseas
cooper
et
al
renal
vascular
lesion
prrsv
infect
sever
mous
strain
infect
murin
cmv
mcmv
disclos
aortic
inflamm
mononuclear
cell
intima
adventitia
cytomegal
inclus
bodi
smooth
muscl
cell
mcmv
antigen
immunohistochemistri
panarter
mononuclear
infiltr
adventitia
media
found
mous
model
infect
viru
suggest
play
import
role
virusinduc
vasculitid
tabl
recent
studi
reveal
signific
correl
reactiv
cell
well
igg
antibodi
suggest
infectioninduc
autoimmun
diseas
relat
potenti
molecular
mimicri
gca
vascul
mainli
tcell
driven
process
trigger
exposur
antigen
probabl
infecti
sudden
onset
variat
incid
differ
geograph
region
led
hypothesi
genet
predisposit
correl
environment
factor
includ
infect
vascul
infecti
trigger
search
biolog
epidemiolog
level
preexist
clinic
infect
suggest
gca
without
epidemiolog
support
even
though
simultan
peak
gcapmr
respiratori
infect
report
candid
pathogen
gca
c
pneumonia
parvoviru
parainfluenza
viru
identifi
pcr
techniqu
andor
serolog
test
author
seem
reinfect
chlamydia
may
induc
vascul
data
confirm
variou
pathogen
anecdot
report
gca
includ
vzv
ebv
cmv
c
psittaci
borrelia
burgdorferi
treponema
pallidum
without
serolog
epidemiolog
basi
tabl
diseas
chronic
vascul
unknown
aetiolog
howev
viral
bacteri
infect
suspect
involv
pathogenesi
diseas
streptococcu
speci
suggest
play
import
role
diseas
stimul
streptococc
antigen
assess
rtpcr
elisa
specif
increas
express
mrna
protein
conjunct
induct
peripher
blood
mononuclear
cell
diseas
patient
oral
streptococcu
infect
classic
report
form
vascul
pathogen
also
occasion
found
tabl
howev
recent
parvoviru
dna
detect
cutan
lesion
patient
diseas
progress
field
made
use
anim
model
infect
instanc
sohn
et
al
report
symptom
icr
mice
induc
hsv
infect
howev
recent
author
suggest
viral
infect
alon
suffici
induc
diseas
immunolog
abnorm
necessari
chlamydia
speci
report
cogan
syndrom
fact
five
case
vascul
serolog
find
indic
c
pneumonia
infect
report
ljungstrom
et
al
howev
preval
microbiolog
studi
anim
model
could
support
correl
cogan
diseas
infect
larg
number
drug
particularli
antibiot
induc
vascul
mainli
cutan
incid
antibioticinduc
vascul
probabl
underestim
druginduc
vasculitid
encount
frequent
secondari
infect
among
drug
frequent
implic
sulphonamid
penicillin
allopurinol
thiazid
hydantoin
aspirin
propylthiouracil
penicillin
caus
vascul
conjug
serum
protein
mediat
immun
complex
vascul
type
iii
hypersensit
reaction
therapeut
agent
virtual
everi
pharmacolog
class
implic
develop
druginduc
vascul
mechan
involv
mainli
relat
immun
complex
arteri
deposit
antigen
excess
drug
propylthiouracil
hydralazin
appear
induc
antibodi
product
specif
anca
although
clear
cut
causal
relationship
yet
prove
clinic
spectrum
druginduc
vascul
consist
mainli
leucocytoclas
hypersensit
vascul
rare
necrot
vasculitid
panlik
syndrom
cerebr
vascul
withdraw
drug
often
follow
prompt
resolut
clinic
manifest
howev
sever
case
requir
corticosteroid
plasmapheresi
haemodialysi
cyclophosphamid
death
report
case
despit
treatment
sometim
system
smallsiz
vessel
vascul
describ
massiv
antigen
inhal
sever
studi
anim
model
shown
inhal
solubl
protein
respiratori
tract
lead
activ
helper
cell
exposur
aerosol
antigen
appear
favour
gener
cell
secret
cytokin
predominantli
support
induct
humor
immun
author
also
identifi
role
cell
exposur
aerosol
protein
implic
control
airway
hyperrespons
ahr
capac
secret
ifn
use
scan
electron
microscopi
fischer
et
al
moor
et
al
report
epitheli
shed
accumul
inflammatori
cell
expect
sign
allerg
airway
inflamm
follow
inhal
aerosol
antigen
immun
guinea
pig
antitnf
treatment
even
though
promis
therapi
vascul
sometim
induc
number
advers
effect
includ
vascul
therefor
recent
case
vascul
therapi
identifi
among
french
patient
receiv
treatment
larger
cohort
patient
autoimmun
diseas
report
januari
decemb
therapi
ramoscas
et
al
case
among
vascul
interestingli
case
vascul
system
present
situat
prognosi
poor
spite
cessat
antitnf
treatment
furthermor
due
interfer
patient
immun
system
antitnf
andor
infliximab
treatment
follow
increas
incid
opportunist
infect
particularli
tuberculosi
also
salmonella
andor
listeria
infect
new
therapi
also
induc
vascul
link
infect
vascul
intrigu
subject
yet
explor
thoroughli
vascul
associ
infect
immun
antimicrobi
drug
infect
report
vasculitid
presum
trigger
factor
situat
one
pathogen
could
respons
variou
type
vascul
eg
hiv
convers
sever
microorgan
could
induc
vasculit
syndrom
pan
howev
instanc
data
come
sporad
case
report
firm
conclus
link
infecti
agent
pathogenesi
vascul
drawn
causal
relationship
infect
vascul
proven
situat
hbv
hcv
pan
cryoglobulinaemia
respect
physiopatholog
complex
relationship
infect
vascul
understood
complet
new
molecular
tool
allow
better
understand
mechan
underli
patholog
may
offer
differ
therapeut
approach
futur
